TAS-IRI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAS-IRI, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer [Phase 2]